Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: Is that true for all the patients?


Eskazan A. E. , Soysal T., Erbilgin Y. , Ozbek U., Ferhanoglu B.

LEUKEMIA RESEARCH, vol.35, no.9, 2011 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Letter
  • Volume: 35 Issue: 9
  • Publication Date: 2011
  • Doi Number: 10.1016/j.leukres.2011.04.025
  • Title of Journal : LEUKEMIA RESEARCH